These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 30368528)

  • 1. IGFBP2 promotes vasculogenic mimicry formation via regulating CD144 and MMP2 expression in glioma.
    Liu Y; Li F; Yang YT; Xu XD; Chen JS; Chen TL; Chen HJ; Zhu YB; Lin JY; Li Y; Xie XM; Sun XL; Ke YQ
    Oncogene; 2019 Mar; 38(11):1815-1831. PubMed ID: 30368528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. METTL3-mediated HOTAIRM1 promotes vasculogenic mimicry icontributionsn glioma via regulating IGFBP2 expression.
    Wu Z; Wei N
    J Transl Med; 2023 Nov; 21(1):855. PubMed ID: 38012763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long Non-Coding RNA HOXA-AS2 Regulates Malignant Glioma Behaviors and Vasculogenic Mimicry Formation via the MiR-373/EGFR Axis.
    Gao Y; Yu H; Liu Y; Liu X; Zheng J; Ma J; Gong W; Chen J; Zhao L; Tian Y; Xue Y
    Cell Physiol Biochem; 2018; 45(1):131-147. PubMed ID: 29310118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JNK mediates insulin-like growth factor binding protein 2/integrin alpha5-dependent glioma cell migration.
    Mendes KN; Wang GK; Fuller GN; Zhang W
    Int J Oncol; 2010 Jul; 37(1):143-53. PubMed ID: 20514406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tenascin-cmediated vasculogenic mimicry formation via regulation of MMP2/MMP9 in glioma.
    Cai HP; Wang J; Xi SY; Ni XR; Chen YS; Yu YJ; Cen ZW; Yu ZH; Chen FR; Guo CC; Zhang J; Ke C; Wang J; Chen ZP
    Cell Death Dis; 2019 Nov; 10(12):879. PubMed ID: 31754182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HNRNPA2B1 stabilizes NFATC3 levels to potentiate its combined actions with FOSL1 to mediate vasculogenic mimicry in GBM cells.
    Wang H; Shi Y; Zhou X; Zhang L; Yang A; Zhou D; Ma T
    Cell Biol Toxicol; 2024 Jun; 40(1):44. PubMed ID: 38862832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factor-binding protein 2-driven glioma progression is prevented by blocking a clinically significant integrin, integrin-linked kinase, and NF-κB network.
    Holmes KM; Annala M; Chua CY; Dunlap SM; Liu Y; Hugen N; Moore LM; Cogdell D; Hu L; Nykter M; Hess K; Fuller GN; Zhang W
    Proc Natl Acad Sci U S A; 2012 Feb; 109(9):3475-80. PubMed ID: 22345562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IGFBP2 potentiates nuclear EGFR-STAT3 signaling.
    Chua CY; Liu Y; Granberg KJ; Hu L; Haapasalo H; Annala MJ; Cogdell DE; Verploegen M; Moore LM; Fuller GN; Nykter M; Cavenee WK; Zhang W
    Oncogene; 2016 Feb; 35(6):738-47. PubMed ID: 25893308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autophagy-induced KDR/VEGFR-2 activation promotes the formation of vasculogenic mimicry by glioma stem cells.
    Wu HB; Yang S; Weng HY; Chen Q; Zhao XL; Fu WJ; Niu Q; Ping YF; Wang JM; Zhang X; Yao XH; Bian XW
    Autophagy; 2017 Sep; 13(9):1528-1542. PubMed ID: 28812437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HNRNPD interacts with ZHX2 regulating the vasculogenic mimicry formation of glioma cells via linc00707/miR-651-3p/SP2 axis.
    Yu S; Ruan X; Liu X; Zhang F; Wang D; Liu Y; Yang C; Shao L; Liu Q; Zhu L; Lin Y; Xue Y
    Cell Death Dis; 2021 Feb; 12(2):153. PubMed ID: 33542193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MMP-2 and MMP-13 affect vasculogenic mimicry formation in large cell lung cancer.
    Li Y; Sun B; Zhao X; Wang X; Zhang D; Gu Q; Liu T
    J Cell Mol Med; 2017 Dec; 21(12):3741-3751. PubMed ID: 28766880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel anti IGFBP2 single chain variable fragment inhibits glioma cell migration and invasion.
    Patil SS; Railkar R; Swain M; Atreya HS; Dighe RR; Kondaiah P
    J Neurooncol; 2015 Jun; 123(2):225-35. PubMed ID: 25944386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glioma progression is mediated by an addiction to aberrant IGFBP2 expression and can be blocked using anti-IGFBP2 strategies.
    Phillips LM; Zhou X; Cogdell DE; Chua CY; Huisinga A; R Hess K; Fuller GN; Zhang W
    J Pathol; 2016 Jul; 239(3):355-64. PubMed ID: 27125842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing the autophagy-specific gene Beclin-1 contributes to attenuated hypoxia-induced vasculogenic mimicry formation in glioma.
    Duan S
    Cancer Biomark; 2018 Feb; 21(3):565-574. PubMed ID: 29278874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factor binding protein 2 enhances glioblastoma invasion by activating invasion-enhancing genes.
    Wang H; Wang H; Shen W; Huang H; Hu L; Ramdas L; Zhou YH; Liao WS; Fuller GN; Zhang W
    Cancer Res; 2003 Aug; 63(15):4315-21. PubMed ID: 12907597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-9 inhibits vasculogenic mimicry of glioma cell lines by suppressing Stathmin expression.
    Song Y; Mu L; Han X; Li Q; Dong B; Li H; Liu X
    J Neurooncol; 2013 Dec; 115(3):381-90. PubMed ID: 24043603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Juglone suppresses vasculogenic mimicry in glioma through inhibition of HuR-mediated VEGF-A expression.
    Luo C; Chen G; Li R; Peng S; Zhang P; Wang F; Yu S; Zhu Y; Zhang J
    Biochem Pharmacol; 2024 Sep; 227():116458. PubMed ID: 39102993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor binding protein 2 promotes glioma development and progression.
    Dunlap SM; Celestino J; Wang H; Jiang R; Holland EC; Fuller GN; Zhang W
    Proc Natl Acad Sci U S A; 2007 Jul; 104(28):11736-41. PubMed ID: 17606927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasculogenic mimicry: a novel target for glioma therapy.
    Chen YS; Chen ZP
    Chin J Cancer; 2014 Feb; 33(2):74-9. PubMed ID: 23816560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of vasculogenic mimicry in human gliomas.
    Liu XM; Zhang QP; Mu YG; Zhang XH; Sai K; Pang JC; Ng HK; Chen ZP
    J Neurooncol; 2011 Nov; 105(2):173-9. PubMed ID: 21533525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.